Nordic Infucare started its journey as an entrepreneurial company with a focus on doing things differently. The business was established to offer specialized treatments for people living with chronic diseases, with the goal of simplifying life and improving patient outcomes. By bridging the gap between medical technology, pharmaceuticals and daily reality, we work toward making life easier for those we serve.
Since the start in 2002, we have grown into a company with more than 100 employees. Today, we are a part of the Air Liquide group, and the patient’s quality of life remains the guide for our actions.
At Nordic Infucare, we share a passion for solving problems and a genuine drive to make a difference. Our focus is on simplifying life for patients, ensuring that complex medical needs become easier to manage. We believe that we achieve the best results by empowering our people and providing the space for creativity.
How will you CONTRIBUTE and GROW?
Nordic Infucare is seeking a passionate and results orientated Key Account Manager to join our Diabetes team in Sweden.
In this field-based role, you will be responsible for driving the success of our Dexcom CGM (Continuous Glucose Measurement) portfolio in the southern part of Sweden. This is an exciting opportunity to positively impact the lives of individuals living with Type- 1 and Type- 2 Diabetes.
Your responsibilities will include:
Developing strong, lasting partnerships with leading diabetes experts (KOLs), healthcare professionals within the Diabetes field, and other key stakeholders.
Implementing effective sales strategies, promoting our innovative diabetes solutions, and expanding product adoption across your territory.
Providing comprehensive training and ongoing support to physicians, nurses, patients, and caregivers on device usage and maintenance.
Providing KOLs with current clinical data and scientific updates to foster understanding and advocacy.
Providing insights and feedback to support commercial strategy.
Are you a MATCH?
The ideal person for this role will have a strong understanding of Type-1 and Type-2 Diabetes, gained through a similar sales role or as a Diabetes Nurse. You will need strong communication skills and a patient focused mindset.
Qualifications:
3-5 years experience in a similar sales role in the MedTech or Pharmaceutical industry
Strong knowledge of Diabetes as a therapy area- Type 1 and Type 2
Degree in Nursing or a Business related field.
Successful sales experience in the General practitioner market (primärvård) is preferable
Excellent relationship-building skills and a passion for supporting healthcare professionals and patients.
Experience from working with patients organizations and tender business is preferable
A clean driving license and willingness to travel regularly within the district This includes overnight stays in hotels.
Fluency in both English and Swedish
What we offer:
We have a competitive benefits package, and long term development opportunities within the business. Benefits include:
Competitive salary and bonus scheme
Company car
Private healthcare
Generous pension scheme
#LI-KM1
Our Differences make our Performance
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.

Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.